The invention provides a liposome for delivery to the posterior segment of the eye, comprising (A) a phospholipid, (B) a charged substance, and/or (C) a membrane-reinforcing substance the liposome having a rigidity that provides the liposome with cell membrane permeability, and having a mean particle diameter of 1 µm or less and a pharmaceutical composition for a disease in the posterior segment of an eye, comprising a drug encapsulated in the liposome. The liposome is delivered to the posterior segment of the eye by instillation, and is non-cytotoxic and the pharmaceutical composition for a disease in the posterior segment of the eye comprises the liposome.
